CB07-Exatecan
Product Sizes
25 mg
£ POA
HY-160015-25MG
50 mg
£ POA
HY-160015-50MG
1 mg
£ POA
HY-160015-1MG
10 mg
£ POA
HY-160015-10MG
5 mg
£ POA
HY-160015-5MG
About this Product
- SKU:
- HY-160015
- Application:
- Antibody Microarray
- CAS Number:
- 2879247-31-9
- Extra Details:
- CB07-Exatecan is an ADC drug-Linker conjugate that can be used for the synthesis of ADCs. ADC conjugated with CB07-Exatecan and trastuzumab inhibits the growth of HER2-positive cancer cells. CB07-Exatecan can be used in cancer research[1].
- Molecular Weight:
- 1472.56
- Purity:
- 98.97
- References:
- [1]Weijia Tang, et al. Method for treating her2-positive solid tumor. Patent WO2023198079A1.
- Research Area:
- Cancer
- Shipping Conditions:
- Ambient
- Storage Conditions:
- -20[o]C; 3 years; 4[o]C; 2 years (Powder)
- Type:
- Proteins, Peptides, Small Molecules & Other Biomolecules: Conjugated Protein
- Pathway:
- Antibody-drug Conjugate/ADC Related;Cell Cycle/DNA Damage
